Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to an uncharacterized, likely non-coding RNA transcript that is transcribed in the antisense orientation relative to the ZMIZ1 gene. Such antisense transcripts are sometimes annotated in genome databases based on transcriptomics data, but they typically lack experimental validation or well-established biological functions. There is currently no evidence that ENSG00000294199 encodes a protein or acts as a receptor, enzyme, transporter, or therapeutic target. In general, antisense RNAs may regulate the expression of their overlapping sense genes through mechanisms like transcriptional interference, RNA duplex formation, or chromatin remodeling, but no such function is confirmed here. ZMIZ1 (Zinc Finger MIZ-Type Containing 1) itself is a well-characterized transcriptional coactivator involved in numerous biological processes, including transcription regulation, lymphatic endothelial cell biology, and neurodevelopmental diseases. The antisense transcript described here is distinct from the protein-coding ZMIZ1 gene and does not appear in disease, drug, or target discovery resources as a standalone entity. This transcript should not be treated as a canonical therapeutic target or receptor, and its entry is only relevant as a genomic annotation artifact, not as a recognized molecule for pharmacological or disease-modifying intervention purposes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel transcript, antisense to ZMIZ1 (ENSG00000294199).